Zscaler delivered its fiscal Q3 print on May 26, and the market's verdict has been swift: the stock held its ground, but the Street spent the following morning cutting price targets almost across the board.
The analyst reaction tells a nuanced story. Bulls have not abandoned the name — 30 buy ratings remain against just 9 holds, and the consensus stays firmly positive — but virtually every firm that published on May 27 lowered its target. UBS trimmed from $260 to $225 while keeping its Buy. Morgan Stanley, the most cautious bellwether in the group, cut from $155 to $145 with an Equal-Weight. BMO dropped to $178 from $210. Citigroup moved to $175 from $205. The direction of travel is uniform: the Street still sees upside from the current $184.60, with a mean target near $198, but expectations for the pace of re-rating have pulled back. The analyst recommendation divergence factor ranks at the 95th percentile of the universe — a signal that the gap between the most optimistic and most cautious views on ZS is unusually wide right now.
The options market had been pricing in exactly this kind of uncertainty. Heading into the print, the put/call ratio climbed to 0.80 — more than two standard deviations above its 20-day mean of 0.65 — reflecting the heaviest demand for downside protection in months. That defensive positioning arrived while the stock was already up 36% on the month, which made it notable: investors were hedging into strength. With the result now in, that PCR reading will be worth watching for mean-reversion as the hedges unwind or roll forward.
Short interest is a secondary story here, not a primary one. At 6.4% of free float — up roughly 19% over the past month in share terms — there has been a steady but unhurried build in bearish positioning since late April. Borrow conditions remain loose, with availability at over 2,100% of outstanding short interest, meaning shares to lend are plentiful and cost to borrow, despite a 19% weekly uptick, remains negligible at just 0.40%. The lending market is not under any strain. Close peer CRWD gained 8.5% on the week, broadly in line with ZS's 5.3% move, while WDAY and NOW each fell roughly 3-4% — a reminder that the bid for cloud security names this week was more selective than the broader SaaS tape.
The bull and bear cases hinge on a familiar tension. Bulls point to low churn, durable renewal economics, the SquareX acquisition, and a valuation that looks cheap relative to cloud-security history — the P/E has expanded roughly 11 points over 30 days to 43x, but bulls argue that reflects earnings momentum rather than multiple expansion. The 12-month forward EPS growth estimate ranks at the 86th percentile. Bears flag rising competition from PANW and Cisco, slower-than-expected traction in products beyond the core ZIA and ZPA platforms, and the risk that larger vendors with existing enterprise relationships continue peeling off new logos. The EPS surprise factor, at the 17th percentile, is a quiet concern — the company has not been consistently beating estimates despite its growth trajectory.
The one confirmed prior earnings reaction in the data — Q2 fiscal 2026 in early March — saw the stock gain 5.1% the day after results and hold those gains over the following week. Whether that pattern repeats now depends less on the headline numbers and more on what management signals about the pace of platform expansion and new customer adds in a market where every competitor is telling the same consolidation story.
See the live data behind this article on ORTEX.
Open ZS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
